Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Companies

Novartis' Ameet Nathwani Joins Sanofi

This article was originally published in Scrip

Executive Summary

Ameet Nathwani has been appointed to Sanofi's executive committee – effective May 1, 2016. Nathwani joins the company from Novartis taking the position of executive vice president, group chief medical officer. From 1994 he held senior leadership roles in research and development in Glaxo, SmithKline Beecham and GlaxoSmithKline PLC. He joined Novartis in 2004 as senior vice president and global development head of the cardiovascular and metabolic franchise and held various senior development and commercial positions over the 11 years he was there. He was appointed global head of medical affairs Novartis Pharma AG in June 2014.

Table

View full table

Topics

Tags:
Companies
Latest Headlines

Diversification Gains Momentum As Companies Look To Derisk China

Finance Watch: Earnings Season Brings Job Cuts, Even At Big Pharma

JLABS Korea, The Next Evolution Of J&J’s Innovation Model

Newron’s Add-On Treatment Shows Promise In Newly Popular Schizophrenia Field

See All
UsernamePublicRestriction

Register

SC064776

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By